LIPO - Lipella Pharmaceuticals, Inc. Quarterly EPS earnings growth
Lipella Pharmaceuticals (LIPO) combines sustainable R&D standards with the outsourcing of trial drug batch production. The quarterly EPS growth rate reflects the company's financial health, where 0.00 determines the latest valuation metric. Business resilience is based on patent law and the success of drug trials for rare diseases.
%20Earnings%20per%20share%20growth%20in%20annualized%20terms%20for%20the%20last%20twelve%20months&width=1200&height=400&colorIndex=0&v=mwhdatcg.m7-7dqbc3k&start=20220704&end=20261115&filename=GURU_Markets_-_LIPO_-_Lipella-Pharmaceuticals_-_Earnings-per-share-growth-in-annualized-terms-for-the-last-twelve-months "lipella.com (LIPO): Year-over-year earnings per share growth for the last twelve months from 04/28/2023 to 07/19/2025 | 👁️GURU.Markets👁️")
Summary analytical data breakdowns for lipella.com (LIPO)
- share price and expert price forecast:
- market capitalization statistics:
- balance sheet net asset value indicators:
- company liabilities and liquidity data:
Total Debt to Capital Lipella Pharmaceuticals|LIPO - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Lipella Pharmaceuticals|LIPO - Company Aggregate Indebtedness|Debts to Book Capitalization Lipella|LIPO - Long-Term Debt|Company Short-Term Debt Lipella Pharmaceuticals|Quick Liquidity lipella.com
- earnings and market multiples details:
LIPO - Company Net Income|Projected Future Earnings Lipella Pharmaceuticals|LIPO - P/E Multiple|Projected Price to Earnings Lipella Pharmaceuticals|LIPO - Growth-Adjusted Payback Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Lipella Pharma|LIPO - Profit before deduction of interest, taxes, depreciation and amortization|Net earnings per share (EPS TTM) Lipella Pharmaceuticals|LIPO - Earnings per share for the trailing year|Quarterly EPS earnings growth lipella.com|LIPO - Earnings growth in current year|Net earnings per share growth forecast for next year Lipella Pharmaceuticals
- sales revenue and business income indicators:
General company analysis:lipella.com - LIPO
For a biotech sector investor, Lipella Pharmaceuticals (LIPO) positions are determined by R&D efficiency and the outsourcing of therapeutic solution production. The earnings per share trend measures the percentage deviation of the current quarterly result from the same period last year, reflecting the actual profitability of the business model. By analyzing the quarterly EPS growth rate, one can assess profit sustainability and the company's long-term capitalization potential.
Analysis of competing companies
HLN: Quarterly EPS earnings growth|Kenvue Corp - Year-over-year earnings per one share growth for the last 12 months|VRNA (Verona Pharma PLC) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months jyongbio.com MENS|Year-over-year earnings per share growth for the last twelve months Ligand (LGND)|AMRX (Amneal) - Year-over-year earnings per one share growth for the last 12 months|Year-over-year earnings per share growth for the last twelve months Perrigo PRGO|Quarterly EPS earnings growth Alvotech Biopharmaceuticals ALVO|liquidia.com - Quarterly EPS earnings growth|GLPG - Quarterly EPS earnings growth|ANIP: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months MNKD|AMPH (Amphastar) - Quarterly EPS earnings growth|Pacira Corp (PCRX) - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months ARS Pharma (SPRY)|Quarterly EPS earnings growth Theravance Biopharma, Inc. (TBPH)|Aquestive Therapeutics - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months SCPH|Tectonic Therapeutic Inc. - Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months TNXP|SXTC (China SXT Pharmaceuticals) - Year-over-year net earnings per share growth for the last 12 months|Eupraxia Pharmaceuticals (EPRX) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months BioHarvest Sciences, Inc.|EXOZ: Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth ORMP|ENTX - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months MindWalk Holdings, Inc. HYFT|Quarterly EPS earnings growth abvcpharma.com ABVC|CPIX - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share trend for the last twelve months QNTM|FGEN (FibroGen Corporation) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months Telomir Pharma|Year-over-year net earnings per share growth for the last 12 months RANI|Earnings per share growth in annualized terms for the last twelve months synergychc.com SNYR|Year-over-year earnings per share growth for the last twelve months Rallybio Corp (RLYB)|LEXX - Earnings per share growth in annualized terms for the last twelve months|Pulmatrix Inc - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months PTHL|Aptorum Group Ltd - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Lyra Therapeutics LYRA|IBO: Quarterly EPS earnings growth|TNFA (TNF Pharma) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months cbdmd.com|Year-over-year earnings per share growth for the last 12 months PRFX (PainReform Corp)|Quarterly EPS earnings growth CYTO|Quarterly EPS earnings growth optinose.com (OPTN)|Year-over-year earnings per share growth for the last twelve months Pieris Pharmaceuticals, Inc. PIRS|Procaps (PROC) - Earnings per share growth in annualized terms for the last twelve months|PTPI - Year-over-year earnings per share growth for the last twelve months|Year-over-year net earnings per share change for the last twelve months Qilian International Corp QLI|SLRN: Quarterly EPS earnings growth|Year-over-year net earnings per share trend for the last twelve months TFFP (tffpharma.com)
